Papers
9
Total Citations
50
H-Index
4
About
Sheng Tai is a pioneering urologic surgeon whose research focuses on advancing robotic-assisted surgery for complex urological conditions, with particular emphasis on prostate cancer recovery, renal tumor management, and the emerging frontier of telesurgery. His most impactful work, a randomized controlled trial on extended nursing care after robot-assisted laparoscopic radical prostatectomy (21 citations), demonstrated significant improvements in postoperative urinary control and quality of life, establishing new standards for patient recovery protocols. Tai has made substantial contributions to renal surgery through systematic reviews comparing surgical approaches in robot-assisted partial nephrectomy and innovative techniques for treating horseshoe kidney, including combined retroperitoneoscopic and transperitoneoscopic accesses. His recent multicenter phase I clinical trial on telesurgery safety in China (2025, 6 citations) represents groundbreaking work in expanding surgical access through remote technology. With over 50 cumulative citations across his publications, Tai has also investigated surgical outcomes in obese urologic patients and developed modified enucleation techniques for highly complex renal tumors, demonstrating consistent dedication to refining surgical approaches for challenging patient populations.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9